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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S58metalloproteinase-13 (MMP-13) level and collagen cleavage. In addition
the ratio of the TGFb type 1 receptors, ALK1 and ALK5, increases with
age. However, there was considerable cell-cell variability in the meas-
ured outcomes. The model shows that the main source of this cellular
heterogeneity is due to the stochastic nature of cellular damage, as most
variability in the model output was seen in the levels of oxidised pro-
teins and AGE products. There was also considerable variability in the
time at which damage starts to accrue, and this accounts for the wide
variability in the activation of matrix degrading enzymes. The model
showed that negative feedback loops in the system are the main con-
tributor to the age-related increase in the ALK1/ALK5 receptor and this
also contributes to the age-related increase in MMP-13 and collagen
degradation.
Conclusions: Age-related changes in cartilage are caused by complex
molecular mechanisms responding to different stress signals. There is
both a gradual increase in damaged components and a dysregulation in
signalling responses with age. Computer modelling is a complementary
approach to assist with unravelling this complexity.
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REDUCED NFAT1 EXPRESSION IS A RISK FACTOR FOR DYSFUNCTION
OF ARTICULAR CHONDROCYTES AND DEVELOPMENT OF
OSTEOARTHRITIS IN AGED MICE
J. Wang, M. Zhang, Q. Lu, J. Crist, C. Theleman, K. Brandt. Univ. of Kansas
Med. Ctr., Kansas City, KS, USA
Purpose: Aging is the overriding risk factor for development of osteo-
arthritis (OA), but the biological mechanisms underlying age-related
predisposition to OA are poorly understood. Our recent studies revealed
that Nfat1 knockout (Nfat1-/-) mice began to show articular chon-
drocyte dysfunction and OA-like changes in the young adult stage. This
study aimed to investigate the role of the transcription factor NFAT1 in
the regulation of articular chondrocyte function in aged mice.
Methods: The hip, knee, and shoulder joints of wild-type BALB/c mice
were harvested at the age of 5, 6, 12, 15, 18, and 24 months for histo-
chemical, immunohistochemical, cellular, and molecular biological
analyses. Nfat1-/- mice with BALB/c background were used as positive
controls. Total RNA isolated from femoral head articular cartilage (AC)
was used for cDNA synthesis and gene expression analyses. Genomic
DNA and chromatins prepared from femoral and humeral head AC were
used for methylated DNA immunoprecipitation and chromatin immu-
noprecipitation (ChIP) assays, respectively. The effects of gene knock-
down or overexpression were examined in cultured articular
chondrocytes.
Results: After 12 months of age, NFAT1 expression in wild-type AC was
signiﬁcantly decreased, in association with focal or generalized loss of
safranin-O staining in AC and a signiﬁcant decrease in expression of
aggrecan and collagen types-II, -IX, and -XI and a signiﬁcant increase
in interleukin-1 beta expression. Forced Nfat1 expression in cultured
articular chondrocytes from aged mice partially reversed the abnormal
metabolic activities. ChIP assays conﬁrmed that the NFAT1 protein
directly binds the promoter regions of Acan, Col11a1, Il1b, Mmp13, and
Tnfa genes, suggesting that these genes are potential downstream
targets of NFAT1. No signiﬁcant difference in DNA methylation of the
Nfat1 promoter was seen between the age groups. However, the level
of speciﬁc histone methylation (H3K4me2, a histone code linked to
transcriptional activation) was signiﬁcantly decreased at the Nfat1
promoter region in AC of aged mice, which was associated with
decreased NFAT1 expression. siRNA-mediated knockdown of lysine-
speciﬁc demethylase-1 (Lsd1) up-regulated Nfat1 expression in cul-
tured chondrocytes from aged mice through enhancement of
H3K4me2 at speciﬁc Nfat1 promoter regions. A majority of the Nfat1-/-
mice (with global loss of NFAT1 function) began to show severe OA
around 12 months of age. By contrast, only 20% of aged mice displayed
severe osteoarthritic changes in the knee joints at the age of 24
months.
Conclusions: The level of NFAT1 expression in AC and other joint tis-
sues affects the initiation and progression of OA in mice. Epigenetic
histone methylation-mediated reduction of NFAT1 expression is a risk
factor for dysfunction of articular chondrocytes and degradation of AC
in aged mice, which predisposes the joint to OA under mechanical
stress.88
DELETION OF MACROPHAGE MIGRATION INHIBITORY FACTOR
REDUCES SEVERITY OF OSTEOARTHRITIS IN MICE
M.A. Greene y, A.L. Roland z, L. Pritzker z, C.S. Carlson z, R.J. Bucala x,
R.A. Miller k, R.F. Loeser, Jr. y. yWake Forest Univ. Sch. of Med., Winston-
Salem, NC, USA; zUniv. of Minnesota, St. Paul, MN, USA; xYale Univ.,
New Haven, CT, USA; kUniv. of Michigan, Ann Arbor, MI, USA
Purpose: Macrophage migration inhibitory factor (MIF) is an
inﬂammatory cytokine that has been studied for its role in the
immune system and in autoimmune diseases including rheumatoid
arthritis and system lupus erythematosus. The function of MIF in
joint tissues and in osteoarthritis has not been previously studied.
MIF has been shown to function as a cytokine that signals through
the CD74 receptor to increase neutrophil and macrophage migration
to regions of inﬂammation. Additionally, MIF promotes macrophage
activation, increasing phagocytosis and destruction of pathogens.
Recently, the deletion of MIF was found to increase the life-span of
mice in an aging study, suggesting a role for MIF in the aging process.
The purpose of the present study was to determine the role of MIF in
age-related OA.
Methods: The stiﬂe joints of 12- and 22-month old MIF-/- andWTmice
(C57BL/6Jx129/SvJae background; n ¼ 13/group) were parafﬁn-
embedded and processed for histology. Midcoronal H&E sections of the
medial tibial plateau (MTP) were analyzed for OA changes using an
articular cartilage structure (ACS) score for cartilage damage (range 0 ¼
normal to 12 ¼ full thickness loss over more than 2/3 of plateau) and by
histomorphometry measurements of cartilage and bone parameters
(Osteometrics). Sections were also analyzed by immunohistochem-
istry. Articular chondrocytes were isolated from normal human adult
ankle (tali) and knee articular cartilage and from knee cartilage
removed at the time of joint replacement for OA. Meniscal cells were
isolated from normal human adult menisci and from menisci removed
at time of joint replacement. Primary conﬂuent cultures were made
serum-free and stimulated with recombinant human MIF (up to 200ng/
ml) over a 2.5-hour time course. Activation of signaling proteins was
measured by immunoblotting of cell lysates, and MMP production was
measured in conditioned media after overnight stimulation. MIF levels
were measured in conditioned media from un-stimulated cells by
human MIF ELISA.
Results: Aged MIF-/- mice (12- and 22-months old) developed less
severe OA than their age- and strain-matched controls as demon-
strated by signiﬁcantly lower articular cartilage structure scores in
MIF-/- mice compared to WT (12-month p ¼ 0.002, 22-month p ¼
0.0045; Fig 1). Knee joints (speciﬁcally the MTP) of WT mice had
increased degradation of the articular cartilage (Fig 2A, arrow 1)
accompanied by thickening of the subchondral bone (Fig 2A, bracket)
and osteophyte formation (Fig 2A, arrow 2) compared to the MIF-/-
joints (Fig 2). OA histomorphometric parameters that were sig-
niﬁcantly different between MIF-/- and WT mice included articular
cartilage area and thickness (reduced in WT), subchondral bone area
and thickness (increased in WT), and the number of viable chon-
drocytes (decreased in WT). MIF IHC results indicated that MIF is
present in the articular cartilage (Fig 2C, arrow 2) and the meniscus
(Fig 2C, arrow 1) of WT mice but is absent in MIF-/- mice (Fig 2D,
arrows 1&2). ELISA analysis of conditioned media from human
chondrocyte and meniscal cell monolayer culture found that these
cultured human cells produce MIF, and that OA chondrocytes produce
signiﬁcantly higher levels of MIF than normal chondrocytes (p ¼
0.005; Fig 3). However, direct stimulation of human chondrocyte or
meniscal cell monolayers with recombinant MIF did not activate
known signaling pathways or increase MMP production as analyzed
by immunoblot of total cell lysates and conditioned media,
respectively.
Conclusions: The deletion of MIF signiﬁcantly reduced the severity of
naturally occurring OA in older adult mice. While human OA chon-
drocytes produced higher levels of MIF than normal chondrocytes, the
addition of exogenous MIF to cells in monolayer had no observable
effect. Therefore, the in vivo effect of MIF on the development of OAmay
be due to macrophage inﬁltration in joint tissues which is currently
being studied. Inhibition of MIF activity may represent a novel ther-
apeutic target in the treatment of OA.
